Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19

• Conditions: Infectious
• Interventions: Diagnostic Test: Laboratory tests

• Registration Number: NCT04490772
• Lead Sponsor: Assiut University

Brief Summary

Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.

Detailed Description

Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and Population (MOH) definitions will be included.The following will be done for all patients:

Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of clinical manifestation such as fever, cough, shortness of breath, sore throat, change in taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of treatment received by the patients will also be described including mechanical ventilation.

Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum ferritin, D-dimer and troponin.

Follow up of the patients will be done until improvement, deaths or complications to determine disease outcomes.

Study Timeline

• Status Verified: 2020-07
• Study Start: 2020-07
• Study First Submitted: 2020-07-20
• Study First Submitted QC: 2020-07-27
• Last Update Submitted: 2020-07-27
• Study First Posted: 2020-07-29
• Last Update Posted: 2020-07-29
• Primary Completion: 2020-09
• Study Completion: 2020-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Confirmed Covid-19 with GIT manifestations

Exclusion Criteria

• Patients refuse to participate

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with Covid-19	Laboratory tests	COVID-19 patients presented with gastrointestinal manifestations

Primary Outcome Measures

Name	Time	Method
Clinical data questionnaire	2 months	Clinical characteristics of age, sex, comorbidities and symptoms.
Tests such as CBC	2 months	Laboratory characters
liver function test	2 months	Laboratory characters